The JSE gained for the first time in four days on Friday as optimism about a viable Covid-19 vaccine being produced in the next few months lifted sentiment, with Sun International among the best performers on the day.
Pfizer Inc and BioNTech said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, news that helped lift sentiment which has been buffeted by concern about the effect of the pandemic on economic activity. Last month the companies clinched a $2bn deal to supply an initial 100-million doses of the vaccine to the US. Meanwhile, Russia is set to start international clinical trials of its Sputnik V vaccine.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
MARKET WRAP: JSE tracks weaker global stocks amid Fed’s glum economic outlookSpain re-emerges as the epicentre of the coronavirus pandemic in Europe after recording the highest number of daily infections on the continent this week
Источник: BDliveSA - 🏆 12. / 63 Прочитайте больше »
WATCH: Is the sun setting on SA’s platinum industry?RMB’s Henk de Hoop talks to Business Day TV about where the platinum industry is headed
Источник: BDliveSA - 🏆 12. / 63 Прочитайте больше »
Mr Price says it has grown market share even as sales slumpThe retailer expects headline earnings per share for its six months to September 28 to fall at least 20%
Источник: BDliveSA - 🏆 12. / 63 Прочитайте больше »